Literature DB >> 2503826

Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia.

T J Kipps1, E Tomhave, L F Pratt, S Duffy, P P Chen, D A Carson.   

Abstract

During fetal development, murine and human B-lineage cells rearrange and express a highly restricted set of immunoglobulin heavy chain variable region genes (VH genes). We noted that a VH gene of the restricted human fetal repertoire, designated 51p1, potentially could encode the VH region of two human IgM rheumatoid factor proteins. These rheumatoid factors share a cross-reactive idiotype (CRI) defined by reactivity with G6, a murine monoclonal antibody that recognizes an antibody heavy chain determinant present on many human IgM autoantibodies, particularly rheumatoid factors. Recently, we found that the G6 CRI also is expressed frequently by neoplastic CD5 (Leu1) B cells from patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma. However, neoplastic CD5-negative B cells from patients with lymphomas of follicular center cell origin rarely express this CRI. Here, we report that G6-reactive leukemic cells from two unrelated CLL patients express a VH gene that shares greater than 99% homology with a rearranged VH gene previously isolated from the leukemic cell DNA of another CLL patient and that is identical to VH 51p1. Using the polymerase chain reaction, we find that this VH gene is rearranged, and presumably expressed, in the genomic DNA of all examined cases of G6-reactive CLL or small lymphocytic lymphoma. Thus these data indicate that the autoantibody-associated G6 CRI is a serologic marker for a conserved and developmentally restricted VH1 gene that is expressed at high frequency in CD5 B-cell malignancies and early B-cell ontogeny.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503826      PMCID: PMC297741          DOI: 10.1073/pnas.86.15.5913

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Phenotypic and functional characterization of human Leu1 (CD5) B cells.

Authors:  N Gadol; K A Ault
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

Review 2.  Regulation of the assembly and expression of variable-region genes.

Authors:  G D Yancopoulos; F W Alt
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

4.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells.

Authors:  S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

5.  The WI-L2-729-HF2 human hybridoma system. Stable hybrids at high frequency.

Authors:  J G Heitzmann; M Cohn
Journal:  Mol Biol Med       Date:  1983-09

Review 6.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

7.  Human B cell development. II. Subpopulations in the human fetus.

Authors:  M Bofill; G Janossy; M Janossa; G D Burford; G J Seymour; P Wernet; E Kelemen
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.

Authors:  J H Antin; S G Emerson; P Martin; N Gadol; K A Ault
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  VH-gene expression in murine lipopolysaccharide blasts distributes over the nine known VH-gene groups and may be random.

Authors:  R Dildrop; U Krawinkel; E Winter; K Rajewsky
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

10.  A common idiotope on human rheumatoid factors identified by a hybridoma antibody.

Authors:  D A Carson; S Fong
Journal:  Mol Immunol       Date:  1983-10       Impact factor: 4.407

View more
  56 in total

Review 1.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

2.  Tumorigenesis mediated by an antigen receptor.

Authors:  H M Jäck; G Beck-Engeser; G Lee; D Wofsy; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 3.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

4.  Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.

Authors:  George F Widhopf; Craig J Goldberg; Traci L Toy; Laura Z Rassenti; William G Wierda; John C Byrd; Michael J Keating; John G Gribben; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2007-08-03       Impact factor: 22.113

Review 5.  Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.

Authors:  Gerard Tobin; Richard Rosenquist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 6.  Properties of polyreactive natural antibodies to self and foreign antigens.

Authors:  T Logtenberg
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

7.  Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Authors:  Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

8.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

Authors:  T J Kipps; S F Duffy
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

9.  Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanisms.

Authors:  F Shokri; R A Mageed; G D Kitas; P Katsikis; H M Moutsopoulos; R Jefferis
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

10.  Sequence analysis of immunoglobulin heavy-chain variable region genes from the synovium of a rheumatoid arthritis patient shows little evidence of mutation but diverse CDR3.

Authors:  C M Brown; K J Fitzgerald; S P Moyes; R A Mageed; D G Williams; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.